Nalaganje...
Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection
The development of new immunosuppressive drugs for kidney transplantation resulted both in better short-term outcomes and in decreased metabolic, cardiovascular, and nephrotoxicity risk. Belatacept belongs to a new class of immunosuppressive drugs that selectively inhibits T-cell activation by preve...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3468025/ https://ncbi.nlm.nih.gov/pubmed/23055693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S27565 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|